Emily J. Meyer

837 total citations
27 papers, 438 citations indexed

About

Emily J. Meyer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Emily J. Meyer has authored 27 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Emily J. Meyer's work include Adrenal Hormones and Disorders (11 papers), Stress Responses and Cortisol (6 papers) and Sepsis Diagnosis and Treatment (6 papers). Emily J. Meyer is often cited by papers focused on Adrenal Hormones and Disorders (11 papers), Stress Responses and Cortisol (6 papers) and Sepsis Diagnosis and Treatment (6 papers). Emily J. Meyer collaborates with scholars based in Australia, New Zealand and United Kingdom. Emily J. Meyer's co-authors include David J. Torpy, Marni A. Nenke, John G. Lewis, Wayne Rankin, David Jesudason, Venkatesan Thiruvenkatarajan, Roelof Van Wijk, Gary Wittert, G.W. Roberts and Tilenka Thynne and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Diabetes Care.

In The Last Decade

Emily J. Meyer

24 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily J. Meyer Australia 12 268 85 72 70 61 27 438
Marianna Minnetti Italy 14 401 1.5× 191 2.2× 33 0.5× 55 0.8× 23 0.4× 55 661
Valeria Hasenmajer Italy 12 423 1.6× 114 1.3× 44 0.6× 32 0.5× 68 1.1× 33 634
Núria Gómez Spain 11 340 1.3× 116 1.4× 111 1.5× 76 1.1× 11 0.2× 23 599
Ty B Carroll United States 13 545 2.0× 258 3.0× 53 0.7× 45 0.6× 73 1.2× 29 673
M Marugo Italy 12 249 0.9× 83 1.0× 53 0.7× 55 0.8× 69 1.1× 37 469
Stephanie Hall Canada 9 117 0.4× 100 1.2× 55 0.8× 50 0.7× 11 0.2× 11 399
Liese Mebis Belgium 15 451 1.7× 50 0.6× 94 1.3× 63 0.9× 13 0.2× 20 688
Mikko Haanpää Finland 9 106 0.4× 25 0.3× 59 0.8× 34 0.5× 25 0.4× 13 331
Susmeeta T. Sharma United States 16 580 2.2× 265 3.1× 31 0.4× 63 0.9× 35 0.6× 21 775
Smita Baid United States 10 577 2.2× 240 2.8× 33 0.5× 20 0.3× 81 1.3× 10 661

Countries citing papers authored by Emily J. Meyer

Since Specialization
Citations

This map shows the geographic impact of Emily J. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily J. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily J. Meyer more than expected).

Fields of papers citing papers by Emily J. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily J. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily J. Meyer. The network helps show where Emily J. Meyer may publish in the future.

Co-authorship network of co-authors of Emily J. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Emily J. Meyer. A scholar is included among the top collaborators of Emily J. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily J. Meyer. Emily J. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Benjamin, P. Hurtado, Mark P. Plummer, et al.. (2026). Harnessing native corticosteroid-binding globulin to treat life-threatening septic shock. Endocrinology. 167(2). 1 indexed citations
2.
Nenke, Marni A., et al.. (2025). Unveiling the novel role of circadian rhythms in sepsis and septic shock: unexplored implications for chronotherapy. Frontiers in Endocrinology. 16. 1508848–1508848. 1 indexed citations
4.
Plummer, Mark P., et al.. (2025). Precision Profiling of Disease Progression in Murine Models of Sepsis and Septic Shock. International Journal of Molecular Sciences. 26(20). 9954–9954.
5.
Chatterjee, Sayantani, et al.. (2025). Impact of different pathogen classes on the serum N-glycome in septic shock. PubMed. 7. 100138–100138.
6.
Umapathysivam, Mahesh M., et al.. (2024). SGLT2 Inhibitor–Associated Ketoacidosis vs Type 1 Diabetes–Associated Ketoacidosis. JAMA Network Open. 7(3). e242744–e242744. 8 indexed citations
7.
Lee, Jessica H., Emily J. Meyer, Marni A. Nenke, Stafford L. Lightman, & David J. Torpy. (2024). Cortisol, Stress, and Disease—Bidirectional Associations; Role for Corticosteroid-Binding Globulin?. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2161–2172. 4 indexed citations
8.
Lee, Jessica H., Zeynep Sumer‐Bayraktar, Parul Mittal, et al.. (2024). Mass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients. Clinica Chimica Acta. 567. 120108–120108. 1 indexed citations
9.
Meyer, Emily J. & Gary Wittert. (2023). Approach the Patient With Obstructive Sleep Apnea and Obesity. The Journal of Clinical Endocrinology & Metabolism. 109(3). e1267–e1279. 17 indexed citations
10.
Lee, Jessica H., et al.. (2023). Corticosteroid-binding globulin (CBG): spatiotemporal distribution of cortisol in sepsis. Trends in Endocrinology and Metabolism. 34(3). 181–190. 14 indexed citations
11.
Thiruvenkatarajan, Venkatesan, et al.. (2022). Peri-colonoscopy Implications of Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Mini-review of Available Evidence. Canadian Journal of Diabetes. 47(3). 287–291. 3 indexed citations
12.
Roberts, G.W., Angela Chen, Tilenka Thynne, et al.. (2021). A comparison of the stress hyperglycemia ratio, glycemic gap, and glucose to assess the impact of stress‐induced hyperglycemia on ischemic stroke outcome. Journal of Diabetes. 13(12). 1034–1042. 45 indexed citations
13.
Frenkel, M, Emily J. Meyer, & James A. Stadler. (2020). Intrathecal Baclofen for Hypertonia Secondary to Glutaric Aciduria Type I. Cureus. 12(6). e8818–e8818. 1 indexed citations
14.
Hodyl, Nicolette A., Michael J. Stark, Emily J. Meyer, et al.. (2020). High binding site occupancy of corticosteroid-binding globulin by progesterone increases fetal free cortisol concentrations. European Journal of Obstetrics & Gynecology and Reproductive Biology. 251. 129–135. 8 indexed citations
15.
Thiruvenkatarajan, Venkatesan, et al.. (2019). Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. British Journal of Anaesthesia. 123(1). 27–36. 106 indexed citations
16.
Nenke, Marni A., Emily J. Meyer, John G. Lewis, et al.. (2017). Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy. Journal of the Endocrine Society. 1(3). 202–210. 23 indexed citations
17.
Sousa, Sunita M C De, Emily J. Meyer, Wayne Rankin, et al.. (2017). Vasculogenic hyperprolactinemia: severe prolactin excess in association with internal carotid artery aneurysms. Pituitary. 20(6). 676–682. 2 indexed citations
18.
Meyer, Emily J., Marni A. Nenke, John G. Lewis, & David J. Torpy. (2017). Corticosteroid-binding globulin: acute and chronic inflammation. Expert Review of Endocrinology & Metabolism. 12(4). 241–251. 19 indexed citations
19.
Meyer, Emily J., Marni A. Nenke, Wayne Rankin, John G. Lewis, & David J. Torpy. (2016). Corticosteroid-Binding Globulin: A Review of Basic and Clinical Advances. Hormone and Metabolic Research. 48(6). 359–371. 92 indexed citations
20.
Bartelink, A. K. M., et al.. (1985). Cerebrospinril fluid rhinorrhea during treatment with bromocriptine for prolactinoma. Neurology. 35(8). 1193–1193. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026